Si-Ning Li

Novel amino acid-substituted diphenylpyrimidine derivatives as potent BTK inhibitors against B cell lymphoma cell lines.

Huijun Sun, Xiaodong Ma, Zhihao Liu, 2018, Bioorganic & medicinal chemistry.

Synthesis and biological activity of imidazole group-substituted arylaminopyrimidines (IAAPs) as potent BTK inhibitors against B-cell lymphoma and AML.

Huijun Sun, Xiaodong Ma, Bin Wu, 2020, Bioorganic chemistry.

Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors.

H. Yin, Huan-qiu Li, Yun-yun Xu, 2015, Bioorganic & medicinal chemistry.

A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer

M. Guan, Fanyang Kong, Xuan Deng, 2021, Cell Death & Disease.

Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.

Huan-qiu Li, G. Ao, Qinghua Hu, 2017, Bioorganic & medicinal chemistry.

Epidermal growth factor receptor inhibitors: a patent review (2010 – present)

Huan-qiu Li, Si-Ning Li, 2014, Expert opinion on therapeutic patents.

Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity.

Huan-qiu Li, Yun-yun Xu, Qing-Hua Hu, 2013, Bioorganic & medicinal chemistry.